Sanofi, Opella, and UCB Joined Clean Heat Program
The pharmaceutical companies partnered with AstraZeneca to decarbonize industrial heat across global supply chains.
Updated on Oct. 14, 2026 in Healthcare
Live Poll
Do you trust that major corporations will genuinely reduce emissions through their supply chain programs?
Sanofi, Opella, and UCB have joined AstraZeneca as founders of the Clean Heat Program to transition manufacturing sites to low-carbon energy. The initiative provides suppliers with technical support and financial incentives to replace fossil-fuel-based steam generation.
Why it matters
The pharmaceutical industry traditionally relies on natural gas-powered boilers, making the transition to low-carbon heat essential for cutting greenhouse gas emissions. Increased natural gas supply constraints have further moved these decarbonization efforts to the forefront of corporate investment agendas.
The program now covers more than 1,000 industrial sites globally. At a plant in Japan, Opella reduced natural gas consumption by 20 percent, while a Merz Therapeutics project in Germany eliminated 1.5 million kilowatt-hours of heating oil and 250 tons of carbon emissions.
The players
AstraZeneca
A global biopharmaceutical company that launched the Clean Heat Program to address supply chain emissions.
Opella
A consumer healthcare company that has begun implementing heat pump technology in its international manufacturing facilities.
Sanofi
A multinational pharmaceutical and healthcare corporation that joined the initiative to standardize sustainable heat solutions.
UCB
A biopharmaceutical firm that committed to the Clean Heat Program to reduce its reliance on fossil fuels.
Merz Therapeutics
A healthcare company that successfully electrified steam production at its German headquarters.
The details
Participating companies are utilizing heat pumps, biomethane, and full electrification to replace traditional fossil fuel heat sources. The initiative is managed by ERM and Secaro, focusing on moving industrial processes away from gas-powered steam boilers.
Timeline
AstraZeneca launched the Clean Heat Program in December 2025.
Sanofi, Opella, and UCB joined the initiative as founders in October 2026.
Market Landscape
This collaborative effort reflects a broader industry shift toward collective supply chain decarbonization to address the decarbonization of industrial process heat in European pharmaceutical supply chains. By pooling resources, these firms are positioning themselves to better mitigate risks associated with regional energy price volatility and sustainability regulations.
For the average consumer, these initiatives aim to stabilize the supply chain against energy-related shocks while aligning pharmaceutical production with environmental goals. The program primarily impacts corporate operational logistics rather than direct retail pricing or product availability.
The takeaway
Companies can significantly reduce industrial carbon footprints by transitioning from fossil fuel boilers to electric heat pumps and biomethane. Adopting these technologies can lead to substantial energy savings and long-term improvements in operational efficiency.
Further reading
Learn more about the latest innovations in Healthcare.
Source note: This article includes information reported by Trellis.
Live Poll
Do you trust that major corporations will genuinely reduce emissions through their supply chain programs?
